These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 816122)

  • 1. [New laboratory test for the study of post-vaccination immunity and evaluation of the protective capacity of intestinal typhus vaccines].
    Levina LA; Kheĭfets LB; Zaĭdner IG; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):40-3. PubMed ID: 816122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
    Kheĭfets LB; Stanislavskiĭ ES; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
    [No Abstract]   [Full Text] [Related]  

  • 3. [Should typhoid-paratyphoid vaccination be continued?].
    Mercier P; Antoine HM
    Bull Acad Natl Med; 1979 May; 163(5):446-50; discussion 450-1. PubMed ID: 15648337
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled field trial with dried sorbed paratyphoid B and typhoid vaccines.
    Hejfec LB; Levina LA; Kuz'minova ML; Slavina AM; Levites NE; Abidov AZ; Goncarova LF
    Bull World Health Organ; 1971; 45(6):787-94. PubMed ID: 5004428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas.
    Whitaker JA; Franco-Paredes C; del Rio C; Edupuganti S
    J Travel Med; 2009; 16(1):46-52. PubMed ID: 19192128
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory characteristics of paratyphoid B vaccines tested in controlled field trials.
    Hejfec LB; Levina LA
    J Bacteriol; 1969 May; 98(2):502-10. PubMed ID: 4977481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective activity of various antigen complexes of typhoid and paratyphoid B vaccines: controlled field trials and laboratory studies.
    Hejfets LB; Levina LA; Bentsianova TG; Salmin LV
    Prog Immunobiol Stand; 1970; 4():561-70. PubMed ID: 4991591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of immunizing properties of precipitated typhoid-paratyphoid vaccine in white mice].
    MAZUR W
    Med Dosw Mikrobiol; 1951; 3(2):185-97. PubMed ID: 14874890
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern practice in immunization. 3. Typhoid and paratyphoid immunization.
    BANKER DD
    Indian J Med Sci; 1957 Jul; 11(7):516 passim. PubMed ID: 13462583
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of new types of chemical vaccines for prevention of intestinal infections and problems with their qualitative evaluation. I. Current aspects of construction and improving and quality of chemical vaccines].
    Karpukhin GI; Shapiro NI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):38-41. PubMed ID: 4218012
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological indices in subjects immunized with typhoid and paratyphoid B antigen IEM vaccine].
    SEMINA NA
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Apr; 30(4):27-32. PubMed ID: 13660410
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typhoid and paratyphoid immunization.
    SCHOFIELD FD
    Practitioner; 1959 Sep; 183():300-4. PubMed ID: 14443406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunogenicity of typhoid and paratyphoid B components of divaccine when used orally (an experimental study)].
    Ianisker GIa; Faĭn VI; Meshalova AN
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):73-7. PubMed ID: 4980673
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vaccination against typhoid/paratyphoid].
    Iwarson S
    Lakartidningen; 1977 Feb; 74(6):409. PubMed ID: 402514
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine.
    Hejfec LB; Levina LA; Kuz'minova ML; Salmin LV; Slavina AM; Vasil'eva AV
    Bull World Health Organ; 1968; 38(6):907-15. PubMed ID: 4973021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects of anti-typhoid-paratyphoid vaccination with inactivated vaccines].
    Dimache G
    Microbiol Parazitol Epidemiol (Bucur); 1972; 17(5):385-94. PubMed ID: 4630431
    [No Abstract]   [Full Text] [Related]  

  • 20. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
    Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.